αααααβααΎαBDX β’ NYSE
add
Becton Dickinson and Co
200.39$
16 ααααΆ, 2:17:19 PM ααααβααα -4 · USD · NYSE · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
α’αΆαααα·α
αα·αααΈαα»α
202.04$
α
αααααααααααα
199.90$ - 205.11$
α
ααααααα½αααααΆαα
α»αααααα
193.03$ - 251.99$
ααΎαβαα»αβααΈααααΆα
57.65Β αααΈααΆα USD
ααα ααα½αααΌαααααα
2.34Β ααΆα
α’αα»ααΆα P/E
33.72
αα·αααααβααΆαααΆα
2.08%
ααΆααααααΌαα
αααα
NYSE
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 5.17Β αααΈααΆα | 9.82% |
α
αααΆαααααα·ααααα·ααΆα | 1.63Β αααΈααΆα | 6.69% |
α
αααΌααα»ααα | 303.00Β ααΆα | 7.83% |
ααααΆααα
αααααα»ααα | 5.86 | -1.84% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 3.43 | 27.99% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 1.40Β αααΈααΆα | 31.20% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 0.98% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 728.00Β ααΆα | -38.41% |
ααααααααα»α | 54.66Β αααΈααΆα | 4.57% |
ααΆαααα½ααα»αααααΌαααα»α | 29.46Β αααΈααΆα | 9.35% |
ααΌαβααααα»α | 25.20Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 287.14Β ααΆα | β |
ααααααααααΉαααααα
| 2.30 | β |
ααα
ααααααΎαααααα | 3.52% | β |
ααα
ααααααΎααΎααα»α | 4.35% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 303.00Β ααΆα | 7.83% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 693.00Β ααΆα | -17.60% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | 204.00Β ααΆα | 187.55% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -1.93Β αααΈααΆα | -123.67% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -1.04Β αααΈααΆα | -322.27% |
ααα αΌαααΆα
αααααΆααααααα | 1.07Β αααΈααΆα | -10.63% |
α’αααΈ
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.
BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023. Wikipedia
CEO
ααΆααααααΎαα‘αΎα
1897
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
74,000
